ProCE Banner Activity

Fixed-Ratio Combination Basal Insulin and GLP-1 RA Therapy in Older Adults: Practical Considerations

Clinical Thought

Here’s my take on the role of fixed-ratio basal insulin and GLP-1 receptor agonist combination regimens in older adults and why monitoring blood sugar is extremely important to avoid hyper- and hypoglycemia.

Released: March 31, 2022

Expiration: March 30, 2023

Share

Faculty

Derek LeRoith

Derek LeRoith, MD, PhD

Full Professor
Physician

Division of Endocrinology
Department of Medicine
Mount Sinai School of Medicine
Mount Sinai Hospital
New York, New York

Provided by

Provided by the University of Cincinnati, in collaboration with ASCP and GAPNA.

ProCE Banner
ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from

Sanofi US

Faculty Disclosure

Primary Author

Derek LeRoith, MD, PhD

Full Professor
Physician

Division of Endocrinology
Department of Medicine
Mount Sinai School of Medicine
Mount Sinai Hospital
New York, New York

Dr Derek LeRoith discusses the role of fixed-ratio combination basal insulin and GLP-1 RA treatment in older adults with type 2 diabetes, from Clinical Care Options (CCO).